United Microelectronics Corporation:企業のM&A・提携・投資分析

◆英語タイトル:United Microelectronics Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:MLINE7099401
◆発行会社(調査会社):MarketLine
◆発行日:2017年5月6日
◆ページ数:64
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:IT・通信
◆販売価格オプション(消費税別)
Single UserUSD350 ⇒換算¥37,800見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD700 ⇒換算¥75,600見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD1,050 ⇒換算¥113,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

United Microelectronics Corporation – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s United Microelectronics Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by United Microelectronics Corporation since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes United Microelectronics Corporation’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by United Microelectronics Corporation. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on United Microelectronics Corporation’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by United Microelectronics Corporation and its subsidiaries since 2007.
- Information about key financial and legal advisors for United Microelectronics Corporation’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about United Microelectronics Corporation’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents

COMPANY OVERVIEW AND KEY FACTS
MERGERS & ACQUISITIONS
–Mergers and Acquisitions – Overview
–Mergers and Acquisitions – Deal reports
CORPORATE VENTURING
–Corporate Venturing – Overview
–Corporate Venturing – Deal reports
PARTNERSHIP
–Partnership – Overview
–Partnership – Deal reports
–Divestments – Deal reports

APPENDIX
–About MarketLine Financial Deals Database
–Deal Definition and Methodology
–About MarketLine
–MarketLine Professional Services Knowledge Center

List of Tables

--United Microelectronics Corporation activity by deal type - volume (trailing twelve months (TTM))
--United Microelectronics Corporation M&A activity by geography (2013 -YTD2017)
--United Microelectronics Corporation activity by deal type - volume (2013 -YTD2017)
--United Microelectronics Corporation M&A average deal size - value ($m) (2013 -YTD2017)
--United Microelectronics Corporation legal advisor ranking by value ($m)
--Top Deals(2013 -YTD2017)
--United Microelectronics Corporation targets and partners (2013 -YTD2017)
--United Microelectronics Corporation M&A volume and value trend (2013-YTD2017)
--United Microelectronics Corporation M&A activity by geography (2013-YTD2017)
--United Microelectronics Corporation corporate venturing volume and value trend (2013-YTD2017)
--United Microelectronics Corporation corporate venturing by geography (2013-YTD2017)
--United Microelectronics Corporation partnership volume and value trend (2013-YTD2017)
--United Microelectronics Corporation partnership trend by key deal type (2013-YTD2017)

List of Figures

--United Microelectronics Corporation activity by deal type - volume (trailing twelve months (TTM))
--United Microelectronics Corporation M&A activity by geography (2013-YTD2017)
--United Microelectronics Corporation activity by deal type - volume (2013-YTD2017)
--United Microelectronics Corporation M&A average deal size - value ($m)
--United Microelectronics Corporation M&A volume and value trend (2013-YTD2017)
--United Microelectronics Corporation M&A activity by geography (2013-YTD2017)
--United Microelectronics Corporation corporate venturing volume and value trend (2013-YTD2017)
--United Microelectronics Corporation corporate venturing by geography (2013-YTD2017)
--United Microelectronics Corporation partnership volume and value trend (2013-YTD2017)
--United Microelectronics Corporation partnership trend by key deal type (2013-YTD2017)

★海外企業調査レポート[United Microelectronics Corporation:企業のM&A・提携・投資分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Goa Carbon Limited (GOACARBON):企業の財務及び戦略的SWOT分析
    Summary Goa Carbon Limited (Goa Carbon) is a petcoke calciner company that manufactures and markets calcined petroleum coke. The company offers calcined petroleum coke to aluminum smelters, graphite electrode and titanium dioxide manufacturers, and chemical and metallurgic industries. It has plants …
  • PTC Inc.:企業のM&A・提携・投資分析
    PTC Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PTC Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Cosmo Pharmaceuticals S.p.A (COPN)(製薬・医療分野):企業M&A動向
    Summary Cosmo Pharmaceuticals S.p.A (Cosmo) is a specialty pharmaceutical company. It undertakes the development, production and marketing of optimized therapies for treatment of gastrointestinal diseases. The company’s pipeline product portfolio includes Lialda /Mezavant /Mesavancol; Uceris/ Cortim …
  • MFEC plcの企業概要及び財務/SWOT分析
    MFEC plc Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts ma …
  • Ryerson Holding Corp:企業の戦略・SWOT・財務分析
    SummaryRyerson Holding Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fi …
  • K S Oils Limited:戦略・SWOT・企業財務分析
    K S Oils Limited - Strategy, SWOT and Corporate Finance Report Summary K S Oils Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Retail Food Group Limited (Foodservice):企業の戦略・SWOT・財務分析
    SummaryRetail Food Group Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of …
  • Novo Nordisk AS (NOVO B):企業のM&A・提携動向(医療機器分野)
    Summary Novo Nordisk A/S (Novo Nordisk), a subsidiary of Novo A/S discovers, develops and manufactures innovative biological medicines. It focuses at developing drugs for treating diabetes and other serious chronic conditions including hemophilia, growth disorders and obesity. The company’s product …
  • Lincoln Educational Services Corporation (LINC):企業の財務及び戦略的SWOT分析
    Summary Lincoln Educational Services Corporation (Lincoln) is an education service provider that operates schools, colleges and technical institutes. The organization offers services such as education training, academic programs and career services. It provides programs in the areas of aesthetics, d …
  • Pherecydes Pharma SA:製品開発パイプライン動向2015
    Pherecydes Pharma SA - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Pherecydes Pharma SA - Product Pipeline Review - 2015’, provides an overview of the Pherecydes Pharma SA’s pharmaceutical research and development focus. This report provides comprehensive information on the curr …
  • Equisnzaroo Co Ltd (058530):企業財務及び戦略的SWOT分析
    Summary Equisnzaroo Co Ltd (Equisnzaroo), formerly Equispharm Co., Ltd. is a biotechnology company that discovers, develops and markets new drugs for various diseases. The company offers products, which include pharospharm, pharospro, pharosbase, IDMap, pharospass and pharoschem. Its PharosDreams is …
  • BRS Resources Ltd. (BRS):企業のM&A・提携動向(石油・ガス分野)
    Summary BRS Resources Ltd. (BRS) is an oil and gas company that offers exploration services. The company explores, develops and produces oil and gas properties in Europe. It has natural gas production sector in Italy. BRS operates various projects related to the coal bed methane, oil fields, hydroca …
  • Nick Scali Ltd (NCK):企業の財務・戦略的SWOT分析
    Nick Scali Ltd (NCK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Enstar Group Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Enstar Group Limited Mergers an …
  • Consolidated Communications Holdings, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Consolidated Communications Hol …
  • Harworth Group plc:企業の戦略・SWOT・財務分析
    SummaryHarworth Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • GW Pharmaceuticals plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' GW Pharmaceuticals plc Mergers …
  • Ignyta Inc (RXDX):企業財務及び戦略的SWOT分析
    Summary Ignyta Inc (Ignyta), formerly NexDx Inc, is a biotechnology company which discovers, develops and commercializes new drugs targeting activated genes in cancer cells for the treatment of cancer patients. It develops products using integrated therapeutic (Rx) and companion diagnostic (Dx) plat …
  • Telormedix SA(製薬・医療分野):企業M&A動向
    Summary Telormedix SA (Telormedix) is a clinical stage biopharmaceutical company. It undertakes the development of immuno-selective drugs for the treatment of cancer and infectious diseases. The company by utilizing the innate immune system technology develops its pipeline products. Its pipeline pro …
  • Dil Ltd (506414):企業財務及び戦略的SWOT分析
    Summary Dil Ltd (Dil) formerly Duphar-Interfran Ltd. is a diversified pharmaceutical company that provides healthcare related products and services. The company offers products in the areas such as biotechnology, environmental solutions, pharmaceuticals, and vitamins. It also provides services such …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆